Abstract

Glucocorticoids (GCs) are known to have a strong impact on the immune system, metabolism, and bone homeostasis. While these functions have been long investigated separately in immunology, metabolism, or bone biology, the understanding of how GCs regulate the cellular cross-talk between innate immune cells, mesenchymal cells, and other stromal cells has been garnering attention rather recently. Here we review the recent findings of GC action in osteoporosis, inflammatory bone diseases (rheumatoid and osteoarthritis), and bone regeneration during fracture healing. We focus on studies of pre-clinical animal models that enable dissecting the role of GC actions in innate immune cells, stromal cells, and bone cells using conditional and function-selective mutant mice of the GC receptor (GR), or mice with impaired GC signaling. Importantly, GCs do not only directly affect cellular functions, but also influence the cross-talk between mesenchymal and immune cells, contributing to both beneficial and adverse effects of GCs. Given the importance of endogenous GCs as stress hormones and the wide prescription of pharmaceutical GCs, an improved understanding of GC action is decisive for tackling inflammatory bone diseases, osteoporosis, and aging.

Highlights

  • Glucocorticoids (GCs) form one major axis of the stress response [1] and are used as immunosuppressive therapeutics in a variety of inflammatory bone diseases [2, 3]

  • Since the first successful treatment of arthritis [6], GCs have been in frequent use and approximately 3% of the elderly population are being treated with GCs [7, 8], to reduce inflammatory symptoms in acute and chronic inflammatory diseases, including rheumatoid and osteoarthritis

  • A “tethering mode” whereby a GC receptor (GR)-monomer interacts with DNA-bound inflammatory transcription factors (NF-κB, AP1, STAT3, IRF3) instead of directly binding to DNA was observed for the repression of genes encoding pro-inflammatory mediators, such as cytokines and matrix metalloproteases [15]

Read more

Summary

Frontiers in Immunology

Glucocorticoids (GCs) are known to have a strong impact on the immune system, metabolism, and bone homeostasis. While these functions have been long investigated separately in immunology, metabolism, or bone biology, the understanding of how GCs regulate the cellular cross-talk between innate immune cells, mesenchymal cells, and other stromal cells has been garnering attention rather recently. GCs do directly affect cellular functions, and influence the cross-talk between mesenchymal and immune cells, contributing to both beneficial and adverse effects of GCs. Given the importance of endogenous GCs as stress hormones and the wide prescription of pharmaceutical GCs, an improved understanding of GC action is decisive for tackling inflammatory bone diseases, osteoporosis, and aging

INTRODUCTION
Glucocorticoids in Osteoimmunology
Cell Autonomous Effects of GCs on Bone
Effects of GCs on Innate Immune Cells
Cells Involved in Fracture Healing
Effects of GCs on Fracture Healing
GC Effects on Osteoarthritis
GC Effects on Osteophytes in Arthritis
Findings
Cell Type Specific GC Action and Crosstalk
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call